OpenSecrets reports that 17 drug companies in TrumpRx boosted lobbying by 23% to over $130M in 2025, outpacing the broader ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results